BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 20847723)

  • 1. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Tomono Y; Inaba S; Senba I; Furuno M; Mogi M; Horiuchi M
    J Hypertens; 2010 Jul; 28(7):1471-81. PubMed ID: 20543712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
    Tomono Y; Iwai M; Inaba S; Mogi M; Horiuchi M
    Am J Hypertens; 2008 Feb; 21(2):206-12. PubMed ID: 18188158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation.
    Iwai M; Chen R; Imura Y; Horiuchi M
    Am J Hypertens; 2007 May; 20(5):579-86. PubMed ID: 17485025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.
    Kanno H; Iwai M; Inaba S; Senba I; Nakaoka H; Sone H; Mogi M; Horiuchi M
    Hypertens Res; 2009 Aug; 32(8):706-11. PubMed ID: 19478815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
    Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
    J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gelatinase inhibition on adipogenesis and adipose tissue development.
    Van Hul M; Bauters D; Himmelreich U; Kindt N; Noppen B; Vanhove M; Lijnen HR
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):49-56. PubMed ID: 22026722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells.
    Lee OH; Seo DH; Park CS; Kim YC
    Biofactors; 2010; 36(6):459-67. PubMed ID: 20806284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
    Kameji H; Mochizuki K; Miyoshi N; Goda T
    Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short term 13-cis-retinoic acid treatment at therapeutic doses elevates expression of leptin, GLUT4, PPARgamma and aP2 in rat adipose tissue.
    Krskova-Tybitanclova K; Macejova D; Brtko J; Baculikova M; Krizanova O; Zorad S
    J Physiol Pharmacol; 2008 Dec; 59(4):731-43. PubMed ID: 19212007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ).
    Krskova K; Filipcik P; Zilka N; Olszanecki R; Korbut R; Gajdosechova L; Zorad S
    J Physiol Pharmacol; 2011 Aug; 62(4):403-10. PubMed ID: 22100841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
    Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
    Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
    Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
    Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice heterozygous for the xanthine oxidoreductase gene facilitate lipid accumulation in adipocytes.
    Murakami N; Ohtsubo T; Kansui Y; Goto K; Noguchi H; Haga Y; Nakabeppu Y; Matsumura K; Kitazono T
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):44-51. PubMed ID: 24158515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.